Intelligene Partners with Kirby Institute to Advance RNA-based Therapeutics Development
ntelligene Inc., a biotechnology company focused on innovative RNA-based therapeutics, and Australia’s Kirby Institute officially signed a partnership agreement under the BRIDGE (Bringing RNA Innovations through the Developmental Gap Effectively) Program on February 7th, 2025.
